Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone + vitamin C + thiamine for septic shock
IRCT20150825023760N7Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of hydrocortisone, ascorbic acid and thiamine in septic shock (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Procalcitonin level change, Lactate level change and 2 more. Started May 2018; status: completed.
02
Drugs
hydrocortisoneascorbic acidthiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20150825023760N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150825023760N7.